Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Abbott Laboratories
Current Parent Company: AbbVie
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $339,148,643
Year: 2012
Date: May 7, 2012
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: consumer protection violation
Mega-Scandal: Improper Drug Marketing
Violation Description: Abbott Laboratories agreed to pay $339 million to settle multistate litigation alleging that it promoted its drug Depakote for uses not approved by the Food and Drug Administration. Of that total, $239 million was part of a larger $1.5 billion civil and criminal settlement also involving the federal government; see the Violation Tracker entry at (click here). The other $100 million came from a separate consumer protection settlement with the states .
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: Illinois
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.